BARD1 and cancer: For example, low expression of BARD1 in HNSC shows a significant correlation with patient survival, suggesting that high expression functions in some way as a positive factor for cancer, whether promoting growth, evasion of the immune system, or resistance to genotoxic agents (Fig. 4).